FDA Inspection 1123693 — Rafarm S.A.
The FDA completed an inspection of Rafarm S.A. on March 11, 2020 in Paiania. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 11, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paiania (Greece)
Additional Details
Bioanalytical BA/BE